Effect of Cyperus squarrosus plant extracts on diabetic neuropathy in Streptozotocin (STZ)–induced diabetic rats
Article Sidebar
-
Diabetic Neuropathy, Cyperus squarrosus, Streptozotocin, Diabetes mellitus, Eddy's Hot Plate, Tail Immersion
Abstract
The present study was designed to evaluate the effects of Cyperus squarrosus plant extracts in streptozotocin-induced diabetic neuropathy. Diabetes was induced by a single administration of streptozotocin (65 mg/kg/intraperitoneally). After 72 hours to measure the fasting blood glucose levels, blood glucose levels more than 220 mg/dl, consider diabetic rats. Animals were divided into six groups, animals untreated with STZ were kept in a normal control group. STZ-induced diabetic rats orally administered with ethanolic and aqueous plant extracts (EECS & AECS) dose 200 & 400 mg/kg, p.o. for eight weeks, Rats were subjected to evaluate serum glucose, biochemical parameters, and test were performed on the initial day, 2n, 4th 6th and 8th week in all groups to evaluate the neuropathy by Eddy’s hot plate and tail immersion test respectively. Diabetic animals were treated with Glibenclamide (5 mg/kg) and plant extracts (200 & 400 mg/kg) for 8 weeks. Groups treated with Glibenclamide (5 mg/kg) and Cyperus squarrosus extracts (200 and 400 mg/kg) significantly reduced elevated serum glucose level & lipid profiles and restored the reduced body weight. After completion of work, we observe the changes in fasting serum glucose, triglysaroids LDL, cholesterol levels are significantly reduced in animals treated with aqueous extract 400mg/kg. Other side animals treated with extracts decrease in the severity of diabetic neuropathy compare with untreated diabetic rats. Finally concluded that Cyperus squarrosus plant exhibit anti-diabetic property and beneficial protection against neuropathy in STZ induced diabetic rats.
Full text article
References
Aida, K., Tawata, M., Shindo, H., Onaya, T., Sasaki, H., Yamaguchi, T., Chin, M., Mitsuhashi, H. 1990. Isoliquiritigenin: A New Aldose Reductase Inhibitor from Glycyrrhizae Radix. Planta Medica, 56(03):254-258.
Akinmoladun, A. C., Ibukun, E. O., Afor, E., Obuotor, E. M., Farombi, E. O. 2007. Pytochemical constituents and antioxidant activity of extract from the leaves of the Ocimum graticcimum. Sci. Res. Essay, 2:163– 166.
Bakırel, T., Bakırel, U., Keleş, O. Ü., Ülgen, S. G., Yardibi, H. 2008. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. Journal of Ethnopharmacology, 116(1):64–73.
Baynes, J. W., Thorpe, S. R. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48(1):1–9.
K R Khandelwal 2002. Practical Pharmacognosy, Ninth Edition, Delhi. Nirali prakashan, pages 149–153.
King, H., Aubert, R. E., Herman, W. H. 1998. Global Burden of Diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21(9):1414–1431.
Kokate, C. K., Purohit, A. P., Gohkale, S. B. 2002. Terpenoids, 21st edition. pages 377–378.
Kushwah, A. S., Kaur, P., Shivanandappa, T. B. 2018. Effect of methanolic extracts of Tectona grandis linn leaves on diabetic neuropathy in streptozotocin-induced diabetic rats. MOJ Drug Design Dev Ther, 2018(4):203–209.
Lehmann, R., Schleicher, E. D. 2000. Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta, 297(1-2):135–144.
Nangle, M., Gibson, T., Cotter, M., Cameron, N. 2006. Effects of Eugenol on Nerve and Vascular Dysfunction in Streptozotocin-Diabetic Rats. Planta Medica, 72(6):494–500.
Nasikkar, S., Mali, P., Bavage, P., Jain, J., 2016. Protective effect of Lagerstroemia speciosa leaves extract against streptozotocin induced diabetic neuropathy in experimental rats. International journal of applaied research, 2016(12):329–337.
Obrosova, I. G., Ilnytska, O., Lyzogubov, V. V., Pavlov, A., Mashtalir, N., Nadler, J. L., Drel, V. R. 2007. High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of “Healthy” Diet and Aldose Reductase Inhibition. Diabetes, 56(10):2598–2608.
Obrosova, I. G., Van Huysen, C., Fathallah, L., Cao, X., Greene, D. A., Stevens, M. J. 2002. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. The FASEB Journal, 16(1):1–26.
Raafat, K., Boukhary, R., Aboul-Ela, M., El-Lakany, A. 2008. Endogenous Lebanese plants treating diabetes and related complications. Natural Products Chemistry and Research, 1(3):112–120.
Ravi, K., Sivagnanam, K., Subramanian, S. 2004. Anti-Diabetic Activity of Eugenia jambolana Seed Kernels on Streptozotocin-Induced Diabetic Rats. Journal of Medicinal Food, 7(2):187–191.
Said, G. 2007. Diabetic neuropathy–a review. Nat Clin Pract Neurol, 3:331–340.
Singh, R., Kaur, N., Kishore, L., Gupta, G. K. 2013. Management of diabetic complications: A chemical constituents based approach. Journal of Ethnopharmacology, 150(1):51–70.
Stopford, R., Winkley, K., Ismail, K. 2013. Social support and glycemic control in type 2 diabetes: A systematic review of observational studies. Patient Education and Counseling, 93(3):549–558.
van Dam, P. S. 2002. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes/Metabolism Research and Reviews, 18(3):176–184.
Yu, J., Zhang, Y., Sun, S. 2006. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol, 84(6):579–87.
Zychowska, M., Rojewska, E., Przewlocka, B., Mika, 2013. Mechanisms and pharmacology of diabetic neuropathy – experimental and clinical studies. Pharmacological Reports, 65(6):1601–1610.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.